Skip to main content

Angiodynamics Value Stock - Dividend - Research Selection

Angiodynamics

ISIN: US03475V1017, WKN: A0B9A5

Market price date: 27.05.2021
Market price: 23,40 USD




Angiodynamics Fundamental data and company key figures of the share

Annual reports in USD
Key figures 08-08-2020
Cash flow
Net operating cash flow -14.554.000
Capital Expenditures -7.585.000
Free cash flow -22.139.000
Balance sheet
Total Equity 455.872.000
Liabilities & Shareholders equity 595.512.000
Income statement
Net income -165.790.000
Eps (diluted) -4,370
Diluted shares outstanding 38.000.000
Net sales/revenue 264.160.000

Fundamental ratios calculated on: 27-05-2021

Ratios
Key figures 27-05-2021
Cash flow
P/C -61,88
   
P/FC -40,16
Balance sheet
ROI-27,84
ROE76,55
Income statement
P/E-5,36
Div. Yield0,00%
P/B1,98
P/S3,37


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolANGO
Market Capitalization900.600.000,00 USD
Country
IndicesNASDAQ Comp.
Sectors
Raw Data SourceUS GAAP in Millionen USD
Stock Split
Internetwww.angiodynamics.com


Description of the company

AngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company's devices are used in minimally invasive, image-guided procedures. The Company offers products within three product groupings: Peripheral Vascular, Vascular Access and Oncology/Surgery. The Company's Peripheral Vascular products include Fluid Management, Venous, Thrombus Management, as well as other core products. The Company's BioFlo products incorporate Endexo Technology into the manufacturing and design of its Vascular Access products. Its Oncology/Surgery product offerings include its Microwave Ablation products, Radiofrequency Ablation (RFA) and its NanoKnife product lines.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.angiodynamics.com